Gilead Sciences (GILD) Interest Expenses (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Interest Expenses data on file, last reported at $240.0 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 7.69% year-over-year to $240.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 2.13% YoY), and the FY2025 full-year result was $1.0 billion, up 4.81% from the prior year.
• Interest Expenses for Q1 2026 stood at $240.0 million, down from $255.0 million in the prior quarter.
• Across five years, Interest Expenses topped out at $260.0 million in Q1 2025 and bottomed at $226.0 million in Q4 2022.
• The 5-year median for Interest Expenses is $240.0 million (2026), against an average of $242.5 million.
• The widest annual swing landed in 2022, when Interest Expenses slipped 8.4%; it then climbed 11.5% in 2023.
• A 5-year view of Interest Expenses shows it stood at $226.0 million in 2022, then grew by 11.5% to $252.0 million in 2023, then dropped by 1.19% to $249.0 million in 2024, then rose by 2.41% to $255.0 million in 2025, then dropped by 5.88% to $240.0 million in 2026.
• The last three Interest Expenses figures came in at $240.0 million (Q1 2026), $255.0 million (Q4 2025), and $256.0 million (Q3 2025), per Business Quant data.

Peer Comparison